Stem cells in the management of heart failure: what have we learned from clinical trials?

References

• Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112(12):e154-235
   PubMed Web of Science ®Google Scholar
• Banasiak W. Diagnostic and therapeutic problems in heart failure. Pol Arch Med Wewn 2008;118(9):485-8
   PubMedGoogle Scholar
• Sun L, Ai J, Wang N, et al. Cerebral ischemia elicits aberration in myocardium contractile function and intracellular calcium handling. Cell Physiol Biochem 2010;26(3):421-30
   PubMedGoogle Scholar
• Murphy SL, Xu JQ, Kochanek KD. Deaths: Preliminary Data for 2010. In: Natl Vital Stat Rep. National Center for Health Statistics; Hyattsville, MD,USA: 2012
   Google Scholar
• Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347(18):1397-402
   PubMed Web of Science ®Google Scholar
• Khan M, Mohsin S, Avitabile D, et al. beta-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ Res 2013;112(3):476-86
   PubMed Web of Science ®Google Scholar
• Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003;100(21):12313-18
   PubMed Web of Science ®Google Scholar
• Oh H, Chi X, Bradfute SB, et al. Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci 2004;1015:182-9
   PubMed Web of Science ®Google Scholar
• Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005;102(25):8966-71
   PubMed Web of Science ®Google Scholar
• Pfister O, Mouquet F, Jain M, et al. CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005;97(1):52-61
   PubMed Web of Science ®Google Scholar
• Marin-Garcia J, Goldenthal MJ. Application of stem cells in cardiology: where we are and where we are going. Curr Stem Cell Res Ther 2006;1(1):1-11
   PubMedGoogle Scholar
• Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 2006;47(9):1777-85
   PubMed Web of Science ®Google Scholar
• Leri A, Kajstura J, Anversa P, Frishman WH. Myocardial regeneration and stem cell repair. Curr Probl Cardiol 2008;33(3):91-153
   PubMed Web of Science ®Google Scholar
• Poss KD. Getting to the heart of regeneration in zebrafish. Semin Cell Dev Biol 2007;18(1):36-45
   PubMed Web of Science ®Google Scholar
• Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344(23):1750-7
   PubMed Web of Science ®Google Scholar
• Chugh AR, Beache GM, Loughran JH, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012;126(11 Suppl 1):S54-64
   PubMed Web of Science ®Google Scholar
• Cesselli D, Beltrami AP, D’Aurizio F, et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011;179(1):349-66
   PubMed Web of Science ®Google Scholar
• Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998;95(15):8801-5
   PubMed Web of Science ®Google Scholar
• Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci USA 2005;102(24):8692-7
   PubMed Web of Science ®Google Scholar
• Kubo H, Jaleel N, Kumarapeli A, et al. Increased cardiac myocyte progenitors in failing human hearts. Circulation 2008;118(6):649-57
   PubMed Web of Science ®Google Scholar
• Wang X, Hu Q, Nakamura Y, et al. The role of the sca-1+/CD31- cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006;24(7):1779-88
   PubMed Web of Science ®Google Scholar
• Huwer H, Winning J, Vollmar B, et al. Long-term cell survival and hemodynamic improvements after neonatal cardiomyocyte and satellite cell transplantation into healed myocardial cryoinfarcted lesions in rats. Cell Transplant 2003;12(7):757-67
   PubMed Web of Science ®Google Scholar
• Gao LR, Wang ZG, Zhang NK, et al. [Transplantation of fetal cardiomyocyte regenerates infarcted myocardium in rats]. Zhonghua Yi Xue Za Zhi 2003;83(20):1818-22
   PubMedGoogle Scholar
• Skobel E, Schuh A, Schwarz ER, et al. Transplantation of fetal cardiomyocytes into infarcted rat hearts results in long-term functional improvement. Tissue Eng 2004;10(5-6):849-64
   PubMedGoogle Scholar
• Caspi O, Huber I, Kehat I, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007;50(19):1884-93
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Chen KY, Naumova AV, et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25(9):1015-24
   PubMed Web of Science ®Google Scholar
• Dawn B, Stein AB, Urbanek K, et al. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 2005;102(10):3766-71
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115(7):896-908
   PubMed Web of Science ®Google Scholar
• Tillmanns J, Rota M, Hosoda T, et al. Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci USA 2008;105(5):1668-73
   PubMed Web of Science ®Google Scholar
• Rota M, Padin-Iruegas ME, Misao Y, et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008;103(1):107-16
   PubMed Web of Science ®Google Scholar
• Ebelt H, Jungblut M, Zhang Y, et al. Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 2007;25(1):236-44
   PubMed Web of Science ®Google Scholar
• Burchfield JS, Dimmeler S. Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis. Fibrogenesis Tissue Repair 2008;1(1):4
   PubMedGoogle Scholar
• Traverse JH, Henry TD, Pepine CJ, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. J Am Med Assoc 2012;308(22):2380-9
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Ellis SG, et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. J Am Med Assoc 2011;306(19):2110-19
   PubMed Web of Science ®Google Scholar
• Oguz E, Ayik F, Ozturk P, et al. Long-term results of autologous stem cell transplantation in the treatment of patients with congestive heart failure. Transplant Proc 2011;43(3):931-4
   PubMed Web of Science ®Google Scholar
• Povsic TJ, O’Connor CM, Henry T, et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am Heart J 2011;162(4):654-62. e651
   PubMed Web of Science ®Google Scholar
• Perin EC, Willerson JT, Pepine CJ, et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. J Am Med Assoc 2012;307(16):1717-26
   Web of Science ®Google Scholar
• Kara RJ, Bolli P, Karakikes I, et al. Fetal cells traffic to injured maternal myocardium and undergo cardiac differentiation. Circ Res 2012;110(1):82-93
   PubMed Web of Science ®Google Scholar
• Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011;8(4):389-98
   PubMed Web of Science ®Google Scholar
• Perin EC, Silva GV, Zheng Y, et al. Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure. Am Heart J 2012;163(3):415-21. e41
   PubMed Web of Science ®Google Scholar
• Qayyum AA, Mathiasen AB, Kastrup J. Stem cell therapy to treat heart ischaemia: implications for diabetes cardiovascular complications. Curr Diab Rep 2014;14(12):554
   PubMed Web of Science ®Google Scholar
• Chou SH, Lin SZ, Kuo WW, et al. Mesenchymal stem cell insights: prospects in cardiovascular therapy. Cell Transplant 2014;23(4-5):513-29
   PubMed Web of Science ®Google Scholar
• Wu K, Mo X, Lu S, Han Z. Retrograde delivery of stem cells: promising delivery strategy for myocardial regenerative therapy. Clin Transplant 2011;25(6):830-3
   PubMed Web of Science ®Google Scholar
• Miyazaki A, Tadokoro H, Drury JK, et al. Retrograde coronary venous administration of recombinant tissue-type plasminogen activator: a unique and effective approach to coronary artery thrombolysis. J Am Coll Cardiol 1991;18(2):613-20
   PubMed Web of Science ®Google Scholar
• O’Cearbhaill ED, Ng KS, Karp JM. Emerging medical devices for minimally invasive cell therapy. Mayo Clin Proc 2014;89(2):259-73
   PubMed Web of Science ®Google Scholar
• Napoli C, William-Ignarro S, Byrns R, et al. Therapeutic targeting of the stem cell niche in experimental hind limb ischemia. Nat Clin Pract Cardiovasc Med 2008;5(9):571-9
   PubMedGoogle Scholar
• Walter DH, Krankenberg H, Balzer JO, et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circ Cardiovasc Interv 2011;4(1):26-37
   PubMed Web of Science ®Google Scholar
• Przybyt E, Harmsen MC. Mesenchymal stem cells: promising for myocardial regeneration? Curr Stem Cell Res Ther 2013;8(4):270-7
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Mei Z, da Graca Cabreira-Hansen M, et al. Manufacturing mesenchymal stromal cells for phase I clinical trials. Cytotherapy 2013;15(4):416-22
   PubMed Web of Science ®Google Scholar
• Bearzi C, Rota M, Hosoda T, et al. Human cardiac stem cells. Proc Natl Acad Sci USA 2007;104(35):14068-73
   PubMed Web of Science ®Google Scholar
• Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94(1):92-5
   PubMed Web of Science ®Google Scholar
• Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364(9429):141-8
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006;27(23):2775-83
   PubMed Web of Science ®Google Scholar
• Sun L, Zhang T, Lan X, Du G. Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis. Clin Cardiol 2010;33(5):296-302
   PubMed Web of Science ®Google Scholar
• Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012;379(9819):895-904
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363(9411):751-6
   PubMed Web of Science ®Google Scholar
• Dib N, Michler RE, Pagani FD, et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005;112(12):1748-55
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V, et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355(12):1222-32
   PubMed Web of Science ®Google Scholar
• Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012;308(22):2369-79
   PubMed Web of Science ®Google Scholar
• Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 2013;61(23):2329-38
   PubMed Web of Science ®Google Scholar